The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback